Find a clinical trial
Breast Cancer
An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer
The following trial is designed to offer pre-approval drug access to iniparib in combination with gemcitabine and carboplatin in order to provide potential clinical benefit to patients with ER-, PR-, and HER2-negative metastatic…
- Trial name
- NCT01130259
- Testing
- iniparib
- Sponsor
- Sanofi
Liver Failure
Use of the ELAD® in Patients With Liver Failure to Provide Expanded Access With Cost Recovery
VTI had established other clinical protocols to study the effects of ELAD® plus standard therapy compared with standard therapy alone in patients with acute on chronic (AOCH) (VTI-201, VTI-206) and fulminant hepatic failure (FHF)…
- Trial name
- NCT00832273
- Testing
- ELAD®
- Sponsor
- Vital Therapies, Inc.
Wound; Rupture, Surgery, Cesarean Section, Postpartum Hemorrhage
HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency
The objective of the Expanded Access Program is to provide HEMOLEVEN, a replacement coagulation factor XI, to patients with severe inherited factor XI deficiency where, in the opinion of the treating physician, the benefits of…
- Conditions
- Wound; Rupture, Surgery, Cesarean Section, Postpartum Hemorrhage, Surgery
- Trial name
- EAP (NCT01701947)
- Testing
- Hemoleven
- Where
- United States
- Sponsor
- Laboratoire français de Fractionnement et de Biotechnologies
Lambert Eaton Myasthenic Syndrome (LEMS)
Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP
Lambert Eaton Myasthenic Syndrome (LEMS) is rare neurological disorder that results in muscle weakness and limited reflex activity.
- Trial name
- NCT01378546
- Testing
- 3,4-diaminopyridine
- Where
- United States
- Sponsor
- Louis H. Weimer, MD
Healthy
A Phase I Clinical Study of the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.
This study is designed to multiple dose and dose escalation study
- Trial name
- HX-1171 (NCT01889745)
- Testing
- HX-1171
- Where
- South Korea
- Sponsor
- Biotoxtech Co., Ltd
Melanoma
Compassionate Use Trial for Unresectable Melanoma With Ipilimumab
The primary objective of the study is to provide treatment with Ipilimumab to subjects who have serious or immediately life-threatening unresectable Stage III or Stage IV melanoma, who have no alternative treatment options, and…
- Trial name
- NCT00495066
- Testing
- Ipilimumab
- Where
- 9 sites in Brazil
- Sponsor
- Bristol-Myers Squibb
Severe Biventricular End Stage Heart Disease
AbioCor Implantable Replacement Heart
Abiocor is a post market approval study for an Implantable Replacement Heart. This post approval study is currently on hold.
- Trial name
- NCT00669357
- Testing
- Abiocor Implantable Replacement Heart
- Sponsor
- Abiomed Inc.
Myelodysplastic Syndromes
An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS)
The purpose of this study is to provide Decitabine to patients with Myelodysplastic syndrome (MDS) of all FAB (French-American-British) subtypes and Intermediate-1, Intermediate-2, and High-Risk International Prognostic Scoring…
- Trial name
- NCT01026376
- Testing
- decitabine
- Where
- 11 sites in Brazil, Hong Kong and 1 more
- Sponsor
- Janssen-Cilag Farmaceutica Ltda.
Breast Reconstruction
Mentor Adjunct Study for Silicone Gel-Filled Mammary Prosthesis
Mentor is undertaking a five-year prospective clinical study designed to collect safety data associated with the implantation of its gel-filled mammary prostheses.
- Trial name
- Adjunct (NCT00948948)
- Testing
- Silicone Gel-Filled Mammary Prostheses
- Where
- United States
- Sponsor
- Mentor Worldwide, LLC
Varicella
Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection
This study is to assess VariZIG™ for the treatment of patients at risk for developing serious complications from chicken pox.
- Trial name
- NCT00338442
- Testing
- VariZIG™
- Sponsor
- Cangene Corporation
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
Treatment Use of Generex Oral-lyn™ in Patients With Diabetes
The objective of this Treatment IND protocol is to provide Generex Oral-lyn™ to patients with serious or life-threatening Type 1 or Type 2 diabetes mellitus, with no satisfactory alternative therapy available for treatment of…
- Trial name
- NCT00948493
- Testing
- Buccal insulin spray
- Sponsor
- Generex Biotechnology Corp.
Philadelphia Chromosome Positive (Ph+) Leukemias, Chronic Myeloid Leukemia
Compassionate Use Ponatinib
The main purpose of this protocol is to provide expanded access to the study drug (Ponatinib/AP24534) for people with imatinib-, dasatinib-, and nilotinib- resistant/intolerant Philadelphia Chromosome Positive (Ph+) Leukemias.
- Trial name
- NCT01549548
- Testing
- Ponatinib
- Where
- United States
- Sponsor
- OHSU Knight Cancer Institute
Mesenchymal Stem Cells
Cartilage Tissue Engineering
In this study, the investigators explored the hypothesis that osteoarthritic cartilage fragments can promote chondrogenesis of MSCs.
- Trial name
- NCT01301664
- Testing
- total knee / hip replacement
- Sponsor
- Chin-Hung Chang
Dravet Syndrome
Stiripentol in Dravet Syndrome
The patient has failed all other available agents and has intractable epilepsy due to Dravet Syndrome. Stiripentol is highly efficacious in Dravet Syndrome.
- Trial name
- NCT01533506
- Testing
- stiripentol
- Where
- United States
- Sponsor
- Mayo Clinic
Byler Disease
Buphenyl Therapy for Byler's Disease
This is a single patient compassionate use protocol to determine whether Buphenyl (4-phenylbutyrate) will improve the poor bile flow associated with Byler Disease.
- Trial name
- NCT01784718
- Testing
- Buphenyl
- Sponsor
- University of Pittsburgh
Medullary Thyroid Cancer
Expanded Access of Cabozantinib in Medullary Thyroid Cancer
The objective of this study is to provide access to cabozantinib for eligible subjects with medullary thyroid cancer (MTC) pending approval of Exelixis' New Drug Application (NDA) by the FDA and commercial availability of…
- Trial name
- NCT01683110
- Testing
- cabozantinib
- Where
- 5 sites in United States
- Sponsor
- Exelixis
Hyperlipidemia
Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia
Previous studies indicate that the variant status of detoxification proteins is different among Taiwanese and other ethnic groups.
- Trial name
- NCT00934258
- Testing
- rosuvastatin,fenofibrate, CYP2C9, UGT1A1, UGT1A3, OATP2, BCRP
- Sponsor
- National Taiwan University Hospital
Arrhythmia
To Validate the Specific Patterns of Magnetocardiography, a Non-invasive Non-contact Examination for Patients With Ischemic Heart Disease or Cardiac Arrhythmia
ECG is one of the most important non-invasive method to diagnose CAD and arrhythmia. However, clinically it still has its limitation.
- Trial name
- NCT00965614
- Testing
- MCG
- Sponsor
- National Taiwan University Hospital
Diabetes, CVD
A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome
Diabetic patients have an excess risk of mortality due to cardiovascular diseases (CVD) compared to non-diabetics. Cardiovascular disease mortality rate is reportedly on the rise in several countries in the region, including…
- Trial name
- NCT00965315
- Testing
- Rosuvastatin,SFC fenofibrate
- Sponsor
- National Taiwan University Hospital
Cystic Fibrosis, Pseudomonas Aeruginosa
Expanded Access Program for Aztreonam Lysine for Inhalation in Canadian Patients With Cystic Fibrosis
This program is to provide expanded access to aztreonam lysine for inhalation (AZLI) prior to its commercial availability to patients with cystic fibrosis (CF) and chronic P.
- Trial name
- EAP (NCT00989807)
- Testing
- Aztreonam lysine
- Where
- 4 sites in Canada
- Sponsor
- Gilead Sciences